Pros | Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | 3/8 | 1/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 9 Years | 7 Years | ||
Fund Size | 1339 Cr | 6460 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.61% | 1.03% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 36 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (7.75%) Max Healthcare Institute Ltd Ordinary Shares (5.65%) HealthCare Global Enterprises Ltd (5.13%) Abbott India Ltd (5.04%) Apollo Hospitals Enterprise Ltd (4.85%) | Sun Pharmaceuticals Industries Ltd (12.83%) Dr Reddy's Laboratories Ltd (9.81%) Cipla Ltd (8%) Divi's Laboratories Ltd (7.48%) Aurobindo Pharma Ltd (6.04%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (95.64%) Basic Materials (4.36%) | Health (97.66%) Basic Materials (1.19%) Financial Services (1.15%) | ||
Equity % | 94.98% | 97.7% | ||
Debt % | - | - | ||
P/E | 42.21 | 31.48 | ||
P/B | 6.76 | 4.31 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -2.3% | -2.17% | ||
3-Month Return | -3.13% | -3.23% | ||
6-Month Return | 2.14% | 2.81% | ||
1-Year Return | -0.99% | 3.25% | ||
3-Year Return | 23.54% | 28.3% | ||
5-Year Return | 16.68% | 18.68% |
Sharpe | 1 | 1.25 | ||
Alpha | 2.62 | 3.97 | ||
Beta | 0.93 | 0.95 | ||
Standard Deviation | 16.06 | 15.7 | ||
Information Ratio | 0.55 | 1.26 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Dharmesh Kakkad,Sharmila D’mello |